Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2012
11/13/2012US8309093 Antibody drug conjugates (ADC) that bind to 24P4C12 proteins
11/13/2012US8309092 Wise binding agents and epitopes
11/13/2012US8309091 CEACAM8-related method for treating autoimmune diseases
11/13/2012US8309090 Monoclonal antibodies for neutralizing anthrax toxin
11/13/2012US8309089 Human cytomegalovirus neutralising antibodies and use thereof
11/13/2012US8309088 Method of treating osteoarthritis with an antibody to NGF
11/13/2012US8309087 Treatment with anti-ErbB2 antibodies
11/13/2012US8309086 antihemophilic factor monoclonal antibodies comprising an immunoglobulin heavy chain and light chain amino acid sequences, with modified by enzymatic deglycosylation or by site directed mutagenesis, used for treating hemostasis disorders; anticoagulants
11/13/2012US8309085 Engineered anti-IL-23R antibodies
11/13/2012US8309084 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
11/13/2012US8309083 Polypeptides involved in immune response
11/13/2012US8309082 Anti-activin A antibodies and uses thereof
11/13/2012US8309077 Stabilized bacteriophage formulations
11/13/2012US8309074 Use of a fermented milk containing L. casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
11/13/2012CA2625156C Adjltvant compositions comprising a mineral salt and another immunostimulating compound
11/13/2012CA2478414C Selective targeting of tumor vasculature using antibody molecules
11/13/2012CA2454587C Stable lyophilized pharmaceutical formulation of igg antibodies
11/13/2012CA2413576C Streptococcus pyogenes antigens
11/13/2012CA2397675C Altered strain of the modified vaccinia virus ankara (mva)
11/13/2012CA2344993C Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus
11/13/2012CA2326692C Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
11/10/2012CA2832022A1 Pharmaceutical compositions for preventing and/or treating an hiv disease in humans
11/08/2012WO2012151578A1 Immunoglobulin-like transcript (ilt) receptors as cd8 antagonists
11/08/2012WO2012151576A1 Methods of treating complications and disorders associated with g-csf administration
11/08/2012WO2012151574A1 Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics
11/08/2012WO2012151517A1 Cochleate compositions and methods of making and using same
11/08/2012WO2012151481A1 Compositions for inhibiting masp-2 dependent complement acitivation
11/08/2012WO2012151468A1 Complement factor b analogs and their uses
11/08/2012WO2012151413A1 Methods for treating prostate cancer
11/08/2012WO2012151391A2 Inactivated virus compositions and methods of preparing such compositions
11/08/2012WO2012151317A1 Vascular disruption agents and uses thereof
11/08/2012WO2012151272A2 T-cell vaccination with viral vectors via mechanical epidermal disruption
11/08/2012WO2012151266A1 Methods for handling biological drugs containing living cells
11/08/2012WO2012151263A2 A synthetic hepatitis c genome and methods of making and use
11/08/2012WO2012151247A2 FORMULATION FOR ANTI-α4β7 ANTIBODY
11/08/2012WO2012150869A1 Antibodies that bind trefoil factors and methods of using same
11/08/2012WO2012150663A1 Improved sugar-coated liposome composition
11/08/2012WO2012150615A1 Identification of a new molecular factor for early diagnosis of urothelial carcinoma of the bladder
11/08/2012WO2012150603A1 Removal of "polyose type" teichoic acid contaminants from bacterial polyoses
11/08/2012WO2012150478A1 Adenovirus vaccine vectors
11/08/2012WO2012149653A1 Modulation of the sonic hedgehog pathway and uses thereof
11/08/2012WO2012149622A1 Skin test for diagnosing subclinical caseous lymphadenitis in goats and sheep
11/08/2012WO2012125569A3 Anti-cd40 antibodies and uses thereof
11/08/2012WO2012122618A8 Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response
11/08/2012WO2012119989A3 Antibodies against cadmi for the diagnosis and treatment of cancer
11/08/2012WO2012118813A3 Anti-il-6 receptor antibodies and methods of use
11/08/2012WO2012110968A3 Treatment of fistulizing crohn's disease
11/08/2012WO2012106251A3 Pertussis vaccine
11/08/2012WO2012103365A9 Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseases
11/08/2012WO2012092569A3 Compositions comprising immunostimulatory nucleic acids and related methods
11/08/2012WO2012033987A3 Anti-human folate receptor beta antibodies and methods of use
11/08/2012US20120283695 Transdermal drug delivery patch and method of controlling drug release of the same by near-ir
11/08/2012US20120283421 Methods and reagents for decreasing clinical reaction to allergy
11/08/2012US20120282701 Dna promoters and antrhax vaccines
11/08/2012US20120282673 Functional mutation in respiratory syncytial virus
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282329 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
11/08/2012US20120282295 Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
11/08/2012US20120282294 Refrigerator-temperature stable influenza vaccine compositions
11/08/2012US20120282293 Multivalent Live Vector Vaccine against Clostridium difficile-Associated Disease
11/08/2012US20120282292 Methods and compositions related to immunogenic fibrils
11/08/2012US20120282291 Vaccine vectors and methods of enhancing immune responses
11/08/2012US20120282290 Mycobacterial Vaccines
11/08/2012US20120282289 Staphylococcal antigens
11/08/2012US20120282288 Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides
11/08/2012US20120282287 Novel Flavivirus Antigens
11/08/2012US20120282286 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
11/08/2012US20120282285 Masp isoforms as inhibitors of complement activation
11/08/2012US20120282284 Methods and compositions for producing antigenic responses
11/08/2012US20120282283 Production of closed linear dna
11/08/2012US20120282282 Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
11/08/2012US20120282281 Agents that Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR)
11/08/2012US20120282280 Bi-specific digoxigenin binding antibodies
11/08/2012US20120282279 Anti-Diabetic Compounds
11/08/2012US20120282278 Anti p2x7 receptor antibodies and fragments thereof
11/08/2012US20120282277 Method for Treating Arteriosclerosis
11/08/2012US20120282276 Biomarkers predictive of progression of fibrosis
11/08/2012US20120282275 Methods and compositions for regulation of neurological conditions
11/08/2012US20120282274 Targeting of the c-terminal segment of c.difficile toxin b for improved clinical diagnosis, prevention, and treatment
11/08/2012US20120282273 Recombinant antibodies against h1n1 influenza
11/08/2012US20120282272 Novel target in the treatment of cytokine release syndrome
11/08/2012US20120282271 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
11/08/2012US20120282270 Formulation of human antibodies for treating tnf-alpha associated disorders
11/08/2012US20120282269 Anti-IL-23 Antibodies
11/08/2012US20120282268 Novel Cell Wall Components of Enterococci and Uses Thereof
11/08/2012US20120282267 Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain
11/08/2012US20120282266 Anti-neoplastic uses of artemin antagonists
11/08/2012US20120282265 Medicament and a method for regulation of the vascular tone
11/08/2012US20120282264 Neutralizing antibodies to hiv-1 and their use
11/08/2012US20120282263 Compositions for inhibiting masp-2 dependent complement activation
11/08/2012US20120282262 Uses and compositions for treatment of psoriasis and crohn's disease
11/08/2012US20120282261 Deuterated analogs of (4S)-4-Ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3', 4':6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof
11/08/2012US20120282260 Anti-herpes simplex virus antibodies and methods of use thereof
11/08/2012US20120282259 Mutant smoothened and methods of using the same
11/08/2012US20120282258 Crlf2 in precursor b-cell acute lymphoblastic leukemia
11/08/2012US20120282257 Single-chain variable fragment (scfv) able to recognize and bind cd99 human protein
11/08/2012US20120282256 Chimeric receptors with 4-1bb stimulatory signaling domain
11/08/2012US20120282255 Methods and compositions for the treatment of alcoholism and alcohol dependence
11/08/2012US20120282254 Cd127 binding proteins
11/08/2012US20120282253 Interleukin-10 antibodies
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 1823